Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02565186
Other study ID # 16890
Secondary ID H8H-CD-LAHL2015-
Status Completed
Phase Phase 3
First received
Last updated
Start date October 7, 2015
Est. completion date August 20, 2019

Study information

Verified date November 2019
Source Eli Lilly and Company
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective, randomized, open-label study in subjects with migraine who have completed the Phase 3 studies, COL MIG 301/LAHJ (NCT02439320) or COL MIG-302/LAHK (NCT02605174) or for a subset of lasmiditan-naïve subjects with migraine. The study is designed to evaluate the safety and tolerability of long-term intermittent use of lasmiditan 100 mg and of lasmiditan 200 mg, as the first dose and as a second dose, for the acute treatment of migraine. Long term efficacy will also be evaluated.


Recruitment information / eligibility

Status Completed
Enrollment 2171
Est. completion date August 20, 2019
Est. primary completion date August 20, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Able and willing to give written informed consent and authorize Health Insurance Portability and Accountability Act (HIPAA).

- Completed COL MIG-301 or COL MIG-302 within the last 12 weeks. Subjects that completed COL MIG-301 prior to COL MIG-305 being available will be allowed to enroll as long as enrollment occurs within 4 weeks of COL MIG-305 activation at their site. (NOTE: Additional subjects may qualify if they completed COL MIG-301 or COL MIG-302 >12 weeks prior or if they have not participated in either prior study, but meet eligibility criteria outlined for COL MIG-302.)

- Females of child-bearing potential must be using or willing to use a highly effective form of contraception (e.g. combined oral contraceptive, intrauterine device (IUD), abstinence or vasectomized partner).

- Able and willing to complete an electronic diary to record details of all migraine attacks treated with study drug.

Exclusion Criteria:

- Any medical condition or clinical laboratory test which in the judgment of the Investigator makes the subject unsuitable for the study.

- Pregnant or breast-feeding women.

- Women of child-bearing potential not using or not willing to use highly effective contraception.

- Participant is at imminent risk of suicide (positive response to question 4 or 5 on the Columbia Suicide Severity Rating Scale (C-SSRS).

- Initiation of or a change in concomitant medication to reduce the frequency of migraine episodes since completing COL MIG-301/LAHJ (NCT02439320) or COL MIG-302/LAHK (NCT02605174).

- Participation in any clinical trial of an experimental drug or device since completing EoS/Visit 2 of COL MIG 301/LAHJ (NCT02439320) or COL MIG-302/LAHK (NCT02605174).

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Lasmiditan
oral tablet

Locations

Country Name City State
Germany Synexus Clinical Research GmbH Berlin
Germany Synexus Clinical Research GmbH Frankfurt am Main Hessen
Germany Synexus Clinical Research GmbH Leipzig Sachsen
Germany Gemeinschaftspraxis für Neurologie und Psychiatrie Westerstede Niedersachsen
United Kingdom Synexus Wales Clinical Research Centre Cardiff South Glamorgan
United Kingdom Synexus Lancashire Clinical Research Centre Chorley Lancashire
United Kingdom Synexus Midlands Clinical Research Center Edgbaston Birmingham
United Kingdom Synexus Scotland Clinical Research Centre Glasgow Strathclyde
United Kingdom Synexus Hexham General Hospital Hexham Northumberland
United Kingdom Kings College Hospital London Greater London
United Kingdom Synexus Manchester Clinical Research Centre Manchester Greater Manchester
United Kingdom Alverton Practice Penzance Cornwall
United Kingdom Synexus Ltd Reading Berkshire
United Kingdom Synexus Merseyside Clinical Research Centre Waterloo Merseyside
United States Radiant Research Akron Ohio
United States Albuquerque Clinical Trials Albuquerque New Mexico
United States Anaheim Clinical Trials, LLC Anaheim California
United States Primary Care Associates Anderson South Carolina
United States Radiant Research Anderson South Carolina
United States Michigan Head, Pain and Neurological Institute Ann Arbor Michigan
United States Asheville Neurology Specialists, PA Asheville North Carolina
United States Atlanta Center of Medical Research Atlanta Georgia
United States Radiant Research Atlanta Georgia
United States Heartland Research Associates Augusta Kansas
United States Mile High Primary Care Aurora Colorado
United States ACRC Trials Austin Texas
United States Central Texas Clinical Research, LLC Austin Texas
United States FutureSearch Trials Austin Texas
United States Tekton Research, Inc Austin Texas
United States Hassman Research Institute Berlin New Jersey
United States Achieve Clinical Research, LLC Birmingham Alabama
United States Alabama Clinical Therapeutics Birmingham Alabama
United States Simon Williamson Clinic Birmingham Alabama
United States Southview Medical Group Birmingham Alabama
United States Northwest Clinical Trials Boise Idaho
United States Boston Clinical Trials Boston Massachusetts
United States Alpine Clinical Research Center Boulder Colorado
United States Nova Clinical Research, LLC Bradenton Florida
United States PAB Clinical Research Brandon Florida
United States West Florissant Internists Bridgeton Missouri
United States Meridien Research Brooksville Florida
United States Radiant Research Carlsbad California
United States The Research Center of Southern California Carlsbad California
United States ACRC Trials Carrollton Texas
United States PMG Research of Cary, LLC Cary North Carolina
United States East Valley Family Physicians, PLC Chandler Arizona
United States Radiant Research Chandler Arizona
United States Warner Family Practice Chandler Arizona
United States Clinical Trials of South Carolina Charleston South Carolina
United States Medical Research South Charleston South Carolina
United States Charlottesville Medical Research Charlottesville Virginia
United States ClinSearch Chattanooga Tennessee
United States Medical and Procedural Specialists of Illinois Chicago Illinois
United States Michigan Avenue Internists Chicago Illinois
United States Radiant Research Chicago Illinois
United States eStudySite Chula Vista California
United States IVA Research Cincinnati Ohio
United States Synexus - US Cincinnati Ohio
United States Rapid Medical Research Inc Cleveland Ohio
United States Ericksen Research and Development Clinton Utah
United States Colorado Springs Family Practice Colorado Springs Colorado
United States Colorado Springs Health Partners, PC Colorado Springs Colorado
United States Columbus Regional Research Institute Columbus Georgia
United States Synexus - US Columbus Ohio
United States Radiant Research, Inc. Council Bluffs Iowa
United States Partners in Clinical Research, LLC Cumberland Rhode Island
United States FutureSearch Trials Dallas Texas
United States Radiant Research - Dallas North Dallas Texas
United States Avail Clinical Research LLC DeLand Florida
United States Clinical Trials of the Rockies Denver Colorado
United States Radiant Research Edina Minnesota
United States Oklahoma City Clinic Edmond Oklahoma
United States Skyline Medical Center Elkhorn Nebraska
United States Regional Clinical Research Endwell New York
United States Evanston Premier Healthcare Research, LLC. Evanston Illinois
United States Synexus - US Evansville Indiana
United States Synexus/Clinical Research Advantage Evansville Indiana
United States Clinical Research West Coast Fort Myers Florida
United States Fountain Hills Family Practice, P.C. Fountain Hills Arizona
United States Prairie Fields Family Medicine, PC Fremont Nebraska
United States Neurological Physicians of Arizona Inc Gilbert Arizona
United States Thomas C. Lenzmeier, M.D., P.C Glendale Arizona
United States Thunderbird Internal Medicine Glendale Arizona
United States Allied Clinical Research Gold River California
United States Mountain View Clinical Research, Inc. Greer South Carolina
United States Radiant Research Greer South Carolina
United States Clinical Investigation Specialists Inc Gurnee Illinois
United States MD Clinical Hallandale Beach Florida
United States Chase Medical Research, LLC Hamden Connecticut
United States Diagnostic Center of Medicine Henderson Nevada
United States Nevada Family Care Henderson Nevada
United States Rita B. Chuang, MD LLC Henderson Nevada
United States Indago Research & Health Center, Inc. Hialeah Florida
United States Infinity Clinical Research, LLC Hollywood Florida
United States Medical Affiliated Research Center Huntsville Alabama
United States Protenium Clinical Research Hurst Texas
United States Goldpoint Clinical Research LLC Indianapolis Indiana
United States Clinical Neuroscience Solutions Inc Jacksonville Florida
United States CNS Research Science, Inc. Jamaica New York
United States The Center For Pharmaceutical Research Kansas City Missouri
United States Clinical Investigation Specialists Inc Kenosha Wisconsin
United States Holston Medical Group Clinical Research Kingsport Tennessee
United States New Orleans Center for Clinical Research Knoxville Tennessee
United States Diagnostic Center of Medicine Las Vegas Nevada
United States Las Vegas Medical Research Las Vegas Nevada
United States Associates in Neurology, PSC Lexington Kentucky
United States Central Kentucky Research Associates Inc Lexington Kentucky
United States Lincoln Research Lincoln Rhode Island
United States Pharmacology Research Institute Los Alamitos California
United States Meridien Research Maitland Florida
United States Urban Family Practice Associates, PC Marietta Georgia
United States Sunstone Medical Research, LLC Medford Oregon
United States Clinical Neuroscience Solutions Inc Memphis Tennessee
United States Advanced Clinical Research LLC Meridian Idaho
United States Central Arizona Medical Associates, PC Mesa Arizona
United States Desert Clinical Research Mesa Arizona
United States Florida Medical Center and Research, Inc. Miami Florida
United States Pharmax Research Clinic Miami Florida
United States Prestige Clinical Research Miami Florida
United States Suncoast Research Group, LLC Miami Florida
United States The Core Research Associates Miami Florida
United States Veritas Research Corp Miami Lakes Florida
United States Ocean Blue Medical Research Center, Inc. Miami Springs Florida
United States Oklahoma City Clinic Midwest City Oklahoma
United States Coastal Carolina Research Center, Inc. Mount Pleasant South Carolina
United States Radiant Research Murray Utah
United States Nashville Neuroscience Group, Inc. Nashville Tennessee
United States New Orleans Center for Clinical Research New Orleans Louisiana
United States Pharmacology Research Institute Newport Beach California
United States Heartland Research Associates Newton Kansas
United States Lynn Institute of Norman Norman Oklahoma
United States Harmony Medical Research Institute, Inc North Miami Beach Florida
United States Comprehensive Psychiatric Care, PC Norwich Connecticut
United States Pacific Research Partners, LLC Oakland California
United States Lynn Health Science Institute Oklahoma City Oklahoma
United States Oklahoma City Clinic Oklahoma City Oklahoma
United States Meridian Clinical Research Omaha Nebraska
United States Quality Clinical Research, Inc. Omaha Nebraska
United States Clinical Neuroscience Solutions Inc Orlando Florida
United States Compass Research Orlando Florida
United States Continuum Health Care Overland Park Kansas
United States Research Integrity, LLC Owensboro Kentucky
United States Thomas Jefferson University Philadelphia Pennsylvania
United States 21st Century Neurology Phoenix Arizona
United States Central Phoenix Med Clinic LLC Phoenix Arizona
United States Family Practice Specialists Ltd Phoenix Arizona
United States Tatum Highlands Medical Associates, PLLC Phoenix Arizona
United States Thunderbird Internal Medicine Phoenix Arizona
United States Radiant Research Pinellas Park Florida
United States ACRC Trials Plano Texas
United States Doctors of Internal Medicine Plano Texas
United States Plano Internal Medicine Associates Plano Texas
United States Clinical Research Institute Plymouth Minnesota
United States Oregon Center for Clinical Investigations, Inc. Portland Oregon
United States Summit Research Network Inc Portland Oregon
United States Beacon Clinical Research, LLC Quincy Massachusetts
United States Desert Valley Research Rancho Mirage California
United States Northern California Clinical Research Center Redding California
United States Anderson Clinical Research Redlands California
United States Clinical Research Partners, LLC Richmond Virginia
United States Rochester Clinical Research, Inc. Rochester New York
United States Harbin Clinic Rome Georgia
United States Clinical Research Center, LLC Royal Palm Beach Florida
United States Radiant Research Saint Louis Missouri
United States Meridien Research Saint Petersburg Florida
United States J. Lewis Research, Inc. Salt Lake City Utah
United States J. Lewis Research, Inc. Salt Lake City Utah
United States Jean Brown Research Salt Lake City Utah
United States Wasatch Clinical Research, LLC Salt Lake City Utah
United States Clinical Trials of Texas, Inc. San Antonio Texas
United States MacGregor Medical Center San Antonio Texas
United States Radiant Research - San Antonio San Antonio Texas
United States Artemis Institute for Clinical Research San Diego California
United States California Research Foundation San Diego California
United States Neurological Research Institute Santa Monica California
United States Radiant Research Santa Rosa California
United States Meridian Clinical Research Savannah Georgia
United States Radiant Research Scottsdale Arizona
United States Schuster Medical Research Institute Sherman Oaks California
United States Jordan River Family Medicine South Jordan Utah
United States Spartanburg Medical Research Spartanburg South Carolina
United States Encompass Clinical Research Spring Valley California
United States Pinnacle Trials, Inc Stockbridge Georgia
United States Infinity Clinical Research, LLC Sunrise Florida
United States Georgia Neurology & Sleep Medicine Associates Suwanee Georgia
United States Multicare Health System Tacoma Washington
United States Meridien Research Tampa Florida
United States Bio Behavioral Health Toms River New Jersey
United States Arizona Community Physicians Tucson Arizona
United States Orange Grove Family Practice Tucson Arizona
United States Radiant Research - Vista CA Vista California
United States Diablo Clinical Research Walnut Creek California
United States West Bay Clinical Research Warwick Rhode Island
United States Palm Beach Research Center West Palm Beach Florida
United States Heartland Research Associates Wichita Kansas
United States Heartland Research Associates Wichita Kansas

Sponsors (2)

Lead Sponsor Collaborator
Eli Lilly and Company CoLucid Pharmaceuticals

Countries where clinical trial is conducted

United States,  Germany,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other Percentage of Participants With Medical Resource Utilization Medical Resource utilization for any cardiovascular (CV) events and/or related resource utilization, such as visits to cardiologists, procedures, hospitalizations, new treatments or treatment adjustments for CV disease and any visits to an emergency room (ER) or physician's office for treatment of migraine was reported. Up to 12 months
Primary Number of Participants With at Least 1 Treatment Emergent Adverse Event An AE with an onset on or within 48 hours after a dose of study drug, or an event that worsened in intensity within 48 hours of a dose of study drug was considered a treatment-emergent adverse event (TEAE).
A summary of serious adverse events (SAEs) and other non-serious adverse events (AEs), regardless of causality, were reported in the Reported Adverse Events module.
Up to 12 months
Secondary Percentage of Migraine Attacks With Pain Freedom (PF) at 2 Hours After Dose Pain freedom is defined as a reduction in headache severity from mild (1), moderate (2), or severe (3) at baseline to none (0). Up to 12 months
Secondary Percentage of Migraine Attacks With Most Bothersome Symptom-Free (MBS) at 2 Hours After Dose MBS-free, defined as the absence of the associated symptom of migraine (nausea, phonophobia, and/or photophobia) at 2 hours postdose that was identified predose as the most bothersome symptom. Up to 12 months
See also
  Status Clinical Trial Phase
Completed NCT01432379 - BOTOX® Prophylaxis in Patients With Chronic Migraine
Completed NCT04084314 - Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study Phase 4
Recruiting NCT05048914 - Migraine Abortive Treatment
Completed NCT03662295 - Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
Completed NCT02766517 - Biomarker Study in Participants With Migraine Early Phase 1
Completed NCT00963937 - Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents Phase 3
Not yet recruiting NCT03632928 - Day to Day Variation of Pressure Pain Threshold and Muscle Hardness
Completed NCT02559895 - A Multicenter Assessment of ALD403 in Frequent Episodic Migraine Phase 3
Completed NCT01435941 - Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine N/A
Completed NCT00743015 - Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks Phase 1
Completed NCT01376141 - Drug Use Investigation for IMIGRAN Tablet N/A
Completed NCT02183688 - Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients Phase 3
Completed NCT03588364 - The Role of Osteopathic Manipulation in the the Management of Post-traumatic Migraine N/A
Completed NCT04091321 - Association Between Chronic Headache and Back Pain With Childbirth
Completed NCT00385008 - TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine Phase 3
Active, not recruiting NCT05888298 - Proximal and Distal Approach GON RFT in Migraine N/A
Completed NCT03435185 - Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients N/A
Recruiting NCT06061588 - "Potential Effects of Virtual Reality Technology on the Treatment of Migraine-Type Headaches" N/A
Completed NCT05658185 - Migraine Difficult to Treat: the Importance of Psychological Care in the Chronic Patient N/A
Recruiting NCT06154070 - An Open Label, Study of DaxibotulinumtoxinA for Migraine Prevention